Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

about

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

Item

http://www.wikidata.org/entity/Q47558279

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

@en

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

@nl

type

Item

label

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

@en

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

@nl

prefLabel

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

@en

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

@nl

P1476

Evaluation of Cognition and Cortical Excitability in Huntington's Disease.

@en

P2093

Abhishek Lenka

http://www.w3.org/2001/XMLSchema#string

B C Nagaraju

http://www.w3.org/2001/XMLSchema#string

Keshav Kumar

http://www.w3.org/2001/XMLSchema#string

M Netravathi

http://www.w3.org/2001/XMLSchema#string

Nitish Kamble

http://www.w3.org/2001/XMLSchema#string

Sanjeev Jain

http://www.w3.org/2001/XMLSchema#string

V Sowmya

http://www.w3.org/2001/XMLSchema#string

P2860

Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity

Corticocortical inhibition in human motor cortex

Huntington's disease: from molecular pathogenesis to clinical treatment.

The FAB: a Frontal Assessment Battery at bedside.

Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion".

Abnormal motor cortex excitability in preclinical and very early Huntington's disease.

Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment.

Intracortical inhibition of the motor cortex is normal in chorea.

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.

Episodic memory impairment in Huntington's disease: a meta-analysis.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/CJN.2017.277

http://www.w3.org/2001/XMLSchema#string

P50

Pramod Kumar Pal

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29307324

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease